Ritlecitinib 50mg capsules
NHS hospitals in England used £24,489,944 of indicative cost of Ritlecitinib 50mg capsules in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 114.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Ritlecitinib 50mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Ritlecitinib 50mg capsules most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £1,662,890 |
| Salford Royal Nhs Foundation Trust | £1,450,887 |
| Western Sussex Hospitals Nhs Found Trust | £794,782 |
| Royal Devon & Exeter Nhs Foundation Trst | £634,205 |
| Chelsea & Westminster Hospital Nhs Ft | £591,482 |
| Barts Health Nhs Trust | £583,887 |
| Aintree University Hospital Nhs Ft | £553,600 |
| Leeds Teaching Hpls Nhs Trust | £541,163 |
| King's College Hpl Nhs Foundation Trust | £528,821 |
| Derby Teaching Hospitals Nhs Found Trust | £499,389 |
The primary-care picture
Ritlecitinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Ritlecitinib medicine page.